Concepedia

Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation

Takehiko Mori, Shiki Okamoto, Reiko Watanabe, Tomoharu Yajima, Yasushi Iwao, Rie Yamazaki, Tomonori Nakazato, Norihide Sato, Tatsuo Iguchi, Hitomi Nagayama,

Bone Marrow Transplantation · 2002 · 61 citations · 37 references

Concepts

MedicineHematologyInfectious DiseasesStem Cell TransplantationTransplant ImmunologyVirologyAntiviral TherapyHematopoietic Stem Cell Transplant PharmacotherapyHematopoietic Stem Cell TransplantationTreatmentCytomegalovirus DiseaseCytomegalovirus Infection ManagementCytomegalovirus TherapyDose Escalation TherapyPost-transplant Cytomegalovirus InfectionPreemptive TherapyReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction Assays

References

37

Real time quantitative PCR.

Chris Heid, Junko Stevens, Kenneth J. Livak et al. · Genome Research · 1996 · 6.2K citations · Full text

Life Sciences, Biotechnology, Molecular Biology +13

1994 Consensus Conference on Acute GVHD Grading.

Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed · 1995 · 5.1K citations

Medicine, Internal Medicine, General Internal Medicine +6

Bone marrow transplant

The Medical Journal of Australia · 1999 · 3.4K citations

Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation

J D Meyers, Nancy Flournoy, E. Donnall Thomas · The Journal of Infectious Diseases · 1986 · 786 citations

Medicine, Hematology, Infectious Diseases +16

Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

J. M. Goodrich · Annals of Internal Medicine · 1993 · 664 citations

Pharmacy, Immunology, Infectious Diseases +17